Adenosine analogues and related method of treatment
申请人:SmithKline Beecham Corporation
公开号:US06407076B1
公开(公告)日:2002-06-18
A compound of formula (I) wherein R2 represents C1-3 alkyl, halogen or hydrogen; R3 represents a fluorinated straight or branched alkyl group of 1-6 carbon atoms; and salts and solvates thereof, in particular, physiologically acceptable solvates and salts thereof. These compounds are agonists of the Adenosine A1 receptor.